当前位置: X-MOL 学术Acta Neuropathol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Elevated expression of the retrotransposon LINE-1 drives Alzheimer’s disease-associated microglial dysfunction
Acta Neuropathologica ( IF 9.3 ) Pub Date : 2024-11-27 , DOI: 10.1007/s00401-024-02835-6
Nainika Roy, Imdadul Haq, Jason C. Ngo, David A. Bennett, Andrew F. Teich, Philip L. De Jager, Marta Olah, Falak Sher

Aberrant activity of the retrotransposable element long interspersed nuclear element-1 (LINE-1) has been hypothesized to contribute to cellular dysfunction in age-related disorders, including late-onset Alzheimer’s disease (LOAD). However, whether LINE-1 is differentially expressed in cell types of the LOAD brain, and whether these changes contribute to disease pathology is largely unknown. Here, we examined patterns of LINE-1 expression across neurons, astrocytes, oligodendrocytes, and microglia in human postmortem prefrontal cortex tissue from LOAD patients and cognitively normal, age-matched controls. We report elevated immunoreactivity of the open reading frame 1 protein (ORF1p) encoded by LINE-1 in microglia from LOAD patients and find that this immunoreactivity correlates positively with disease-associated microglial morphology. In human iPSC-derived microglia (iMG), we found that CRISPR-mediated transcriptional activation of LINE-1 drives changes in microglial morphology and cytokine secretion and impairs the phagocytosis of amyloid beta (Aβ). We also find LINE-1 upregulation in iMG induces transcriptomic changes genes associated with antigen presentation and lipid metabolism as well as impacting the expression of many AD-relevant genes. Our data posit that heightened LINE-1 expression may trigger microglial dysregulation in LOAD and that these changes may contribute to disease pathogenesis, suggesting a central role for LINE-1 activity in human LOAD.



中文翻译:


反转录转座子 LINE-1 表达升高驱动阿尔茨海默病相关的小胶质细胞功能障碍



反转录转座因子长散布核元件 1 (LINE-1) 的异常活性已被假设会导致年龄相关疾病的细胞功能障碍,包括迟发性阿尔茨海默病 (LOAD)。然而,LINE-1 是否在 LOAD 脑的细胞类型中差异表达,以及这些变化是否会导致疾病病理在很大程度上是未知的。在这里,我们检查了 LOAD 患者和认知正常、年龄匹配的对照的人类死后前额叶皮层组织中神经元、星形胶质细胞、少突胶质细胞和小胶质细胞的 LINE-1 表达模式。我们报道了 LOAD 患者小胶质细胞中由 LINE-1 编码的开放阅读框 1 蛋白 (ORF1p) 的免疫反应性升高,并发现这种免疫反应性与疾病相关的小胶质细胞形态呈正相关。在人 iPSC 衍生的小胶质细胞 (iMG) 中,我们发现 CRISPR 介导的 LINE-1 转录激活驱动小胶质细胞形态和细胞因子分泌的变化,并损害 β 淀粉样蛋白 (Aβ) 的吞噬作用。我们还发现 iMG 中的 LINE-1 上调诱导与抗原呈递和脂质代谢相关的转录组变化基因,并影响许多 AD 相关基因的表达。我们的数据假设 LINE-1 表达升高可能会触发 LOAD 中的小胶质细胞失调,并且这些变化可能有助于疾病发病机制,表明 LINE-1 活性在人类 LOAD 中起着核心作用。

更新日期:2024-11-29
down
wechat
bug